SEC Filing Summary: Second Sight Medical Products, Inc.
Business Context and Reporting Period
This Form 8-K was filed by Second Sight Medical Products, Inc. (trading symbol: EYES) on August 6, 2019. The filing serves to announce financial results for the three-month and six-month periods ended June 30, 2019. The registrant is an emerging growth company incorporated in California.
Key Financial Metrics
The filing text itself does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached earnings release (Exhibit 99.1), which is referenced but not included in the provided text.
Material Changes
The filing does not detail specific material changes versus prior periods within the main text. It directs readers to the attached earnings release for a comparison of the three-month and six-month periods ended June 30, 2019, against prior comparable periods.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, specific risk factors, or details on contingencies. It explicitly states that the information in Item 2.02 and Exhibit 99.1 is furnished and not deemed "filed" for purposes of Section 18 of the Exchange Act, nor incorporated by reference except as expressly set forth.
Investor Verification Checklist
- Review Exhibit 99.1 (Earnings Release) for actual revenue, net loss, and cash position figures.
- Verify the specific year-over-year and quarter-over-quarter changes in operating expenses and R&D spending.
- Confirm the company's cash runway and any recent financing activities mentioned in the full earnings release.
- Check for any updates on the regulatory status of the Argus II Retinal Prosthesis System or other product pipelines.